Dswiss INC (DQWS) — SEC Filings

Q: What are the key financial highlights for Dswiss INC?

Key financial highlights for Dswiss INC are extracted from the most recent 10-K or 10-Q filings, including revenue, net income, EPS, debt-to-equity, cash position, and operating margin.

Q: Who are the key executives at Dswiss INC?

Key executives at Dswiss INC are identified from SEC filings including 10-K annual reports, proxy statements, and insider trade forms.

Q: What are the main risk factors for Dswiss INC stock?

Risk factors for Dswiss INC (DQWS) are assessed from SEC filings using AI analysis. Each filing is categorized as high, medium, or low risk based on disclosed risk factors and financial indicators.

Q: What are recent predictions and forward guidance from Dswiss INC?

Forward-looking statements and predictions from Dswiss INC are extracted from SEC filings including earnings reports, annual reports, and current event filings.

Latest SEC filings for Dswiss INC. Recent 10-K filing on Mar 31, 2026. AI-decoded analysis of earnings, risk factors, and insider trades.

View Dswiss INC on SEC EDGAR

Overview

Dswiss INC (DQWS) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-K filed on Mar 31, 2026: DSwiss Inc. (DQWS) reported for the fiscal year ended December 31, 2025, operating primarily in the supply of high-quality health and beauty products, including weight management beverages, anti-aging solutions, and immune system enhancers. The company, incorporated on May 28, 2015, in Nevada, condu

Sentiment Summary

Across 10 filings, the sentiment breakdown is: 1 bullish, 2 bearish, 7 neutral. The dominant filing sentiment for Dswiss INC is neutral.

Filing Type Overview

Dswiss INC (DQWS) has filed 3 10-K, 6 10-Q, 1 8-K with the SEC between Mar 2024 to Mar 2026.

Filings by Year

2026 · 2025 · 2024

Recent Filings (10)

DSwiss Expands Global Footprint in Health & Beauty ODM/OEM Market — 10-K · Mar 31, 2026 Risk: medium
DSwiss Inc. (DQWS) reported for the fiscal year ended December 31, 2025, operating primarily in the supply of high-quality health and beauty products, including
DSwiss Revenue Up, But Q3 Loss Widens Amid Going Concern Doubts — 10-Q · Nov 14, 2025 Risk: high
DSwiss Inc. (DQWS) reported a mixed financial performance for the nine months ended September 30, 2025. While revenue increased by 18.5% to $2,464,144 from $2,0
DSwiss Inc. Files 8-K on Officer/Director Changes — 8-K · Oct 6, 2025 Risk: medium
DSwiss Inc. filed an 8-K on October 6, 2025, reporting events as of October 1, 2025. The filing pertains to the departure of directors or certain officers, elec
DSwiss Revenue Surges 92.5% Amidst Going Concern Doubts — 10-Q · Aug 14, 2025 Risk: high
DSwiss Inc. (DQWS) reported a significant increase in revenue for the six months ended June 30, 2025, reaching $2,022,526, a 92.5% increase from $1,050,744 in t
DSwiss Inc. Files Q1 2025 10-Q — 10-Q · May 15, 2025 Risk: low
DSwiss Inc. filed its 10-Q for the period ending March 31, 2025. The filing includes financial data for the first quarter of 2025 and comparative periods. The c
DSwiss Inc. Files 2024 10-K — 10-K · Mar 31, 2025 Risk: low
DSwiss Inc. filed its 10-K for the fiscal year ending December 31, 2024, on March 31, 2025. The company, incorporated in Nevada, operates in the perfumes, cosme
DSwiss Inc. Files Q3 2024 10-Q Report — 10-Q · Nov 14, 2024 Risk: low
DSwiss Inc. filed its 10-Q for the period ending September 30, 2024. The filing details financial information for the third quarter and the first nine months of
DSwiss Inc. Files Q2 2024 10-Q — 10-Q · Aug 14, 2024 Risk: low
DSwiss Inc. filed its 10-Q for the period ending June 30, 2024. The filing details financial information for the company, which is incorporated in Nevada and op
DSwiss Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 15, 2024 Risk: low
DSwiss Inc (DQWS) filed a Quarterly Report (10-Q) with the SEC on May 15, 2024. DSwiss Inc. filed a 10-Q report for the period ending March 31, 2024. The filing
DSwiss Inc. Files 2023 Annual Report (10-K) — 10-K · Mar 29, 2024 Risk: low
DSwiss Inc (DQWS) filed a Annual Report (10-K) with the SEC on March 29, 2024. DSwiss Inc. filed its 10-K annual report for the fiscal year ending December 31,

Risk Profile

Risk Assessment: Of DQWS's 10 recent filings, 2 were flagged as high-risk, 2 as medium-risk, and 6 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Key Executives

Vincent Leong

Industry Context

DSwiss operates within the competitive health and beauty and nutraceutical sectors, characterized by a growing consumer demand for natural ingredients and science-backed wellness solutions. The company leverages its expertise as a biotech firm and ODM/OEM provider to cater to this demand. Key industry trends include personalized nutrition, anti-aging solutions, and immune system support, areas where DSwiss appears to be focusing its product development.

Top Tags

10-Q (4) · financials (4) · Nutraceuticals (2) · 10-K (2) · quarterly-report (2) · DSwiss Inc. (2) · Skincare (1) · OEM/ODM (1) · International Expansion (1) · Health & Beauty (1)

Key Numbers

Fiscal Year End Date: 2025-12-31 — The period covered by this 10-K filing.
Common Stock Outstanding: 206,904,585 — Number of shares outstanding as of December 31, 2025.
Incorporation Date: 2015-05-28 — Date DSwiss, Inc. was incorporated in Nevada.
Acquisition Date: 2023-01-18 — Date DSwiss (HK) Limited acquired remaining 60% of DSwiss Biotech Sdn Bhd.
Acquisition Consideration: RM1 — The price paid for the remaining 60% equity interest in DSwiss Biotech Sdn Bhd.
Revenue for nine months ended Sep 30, 2025: $2,464,144 — Increased by 18.5% from $2,077,942 in 2024
Net loss for three months ended Sep 30, 2025: $97,891 — Widened from $61,468 net loss in 2024
Net income for nine months ended Sep 30, 2025: $72,973 — Decreased from $137,343 in 2024
Accumulated deficit as of Sep 30, 2025: $1,314,957 — Indicates significant historical losses and raises going concern doubts
Negative operating cash flow for nine months ended Sep 30, 2025: $18,597 — Contributes to going concern doubts
Total Assets as of Sep 30, 2025: $800,748 — Increased from $635,830 at Dec 31, 2024
Gross profit for three months ended Sep 30, 2025: $58,569 — Decreased from $113,201 in 2024
Common shares outstanding: 206,904,585 — Consistent across periods
Revenue for six months ended June 30, 2025: $2,022,526 — Increased 92.5% from $1,050,744 in H1 2024
Net income for six months ended June 30, 2025: $170,864 — Decreased 14.06% from $198,811 in H1 2024

Frequently Asked Questions

What are the latest SEC filings for Dswiss INC (DQWS)?

Dswiss INC has 10 recent SEC filings from Mar 2024 to Mar 2026, including 6 10-Q, 3 10-K, 1 8-K. Each filing includes an AI-generated plain-English summary.

What is the overall sentiment of DQWS filings?

Across 10 filings, the sentiment breakdown is: 1 bullish, 2 bearish, 7 neutral. The dominant sentiment is neutral.

Where can I find Dswiss INC SEC filings explained simply?

ReadTheFiling provides AI-powered plain-English summaries of all Dswiss INC (DQWS) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.

What are the key financial highlights for Dswiss INC?

Key financial highlights from Dswiss INC's most recent 10-K include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.

What is the investment thesis for DQWS?

The investment thesis for DQWS includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.

Who are the key executives at Dswiss INC?

Key executives identified across Dswiss INC's filings include Vincent Leong.

What are the main risk factors for Dswiss INC stock?

Of DQWS's 10 assessed filings, 2 were flagged high-risk, 2 medium-risk, and 6 low-risk.

What are recent predictions and forward guidance from Dswiss INC?

Forward guidance and predictions for Dswiss INC are extracted from SEC filings as they are enriched.